The FDA decision on Sanofi’s (SNY) request to expand the age indication of flu vaccine Fluzone Quadrivalent of 0.5-mL dose to include children 6 through 35 months of age is slated for January 28, 2019. Currently, only individuals aged 36 months and older can be administered a 0.5-mL dose. For children aged between 6 and 35 months, the approved dose of Fluzone Quadrivalent is 0.25-mL.Fluzone Quadrivalent is effective against four different strains of flu - two influenza A viruses and two influenza B viruses.SNY closed Friday’s (Dec.21, 2018) trading at $42.32, down 2.06%.